Merck & Co., Inc: all 2,453 studies
Page 15 of 25. Open to participants first (145), then studies with results posted, then the rest; newest registration first within each.
- Dose-Range Finding Study for MK0893 (0893-008)TerminatedNCT00479466Phase 2Results posted
- Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)CompletedNCT00479388Phase 3Results posted
- Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1)CompletedNCT00479232Phase 1Results posted
- A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED)CompletedNCT00475735Phase 2Results posted
- Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or Having a Past History of Pulmonary Disease (19.4.308) (P05932) (MK-8616-017)CompletedNCT00475215Phase 3Results posted
- Comparison of the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616; Org 25969) in Elderly Participants With Adult Participants (MK-8616-029)CompletedNCT00474617Phase 3Results posted
- Comparison of Recovery From Rocuronium 1.2 mg/kg Followed by Sugammadex (Org 25969) 16 mg/kg at 3 Minutes With Recovery From Succinylcholine 1.0 mg/kg (19.4.303)(P05946)(MK-8616-026)CompletedNCT00474253Phase 3Results posted
- A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056)TerminatedNCT00473889Phase 2/3Results posted
- Comparison of Sugammadex (MK-8616/Org 25969) With Neostigmine Administered at 1-2 Post-tetanic Counts (PTCs) After Administration of Rocuronium or Vecuronium (19.4.302/P05945/MK-8616-025)CompletedNCT00473694Phase 3Results posted
- PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)CompletedNCT00468728Phase 3Results posted
- A Study of V950 in People With Alzheimer Disease (V950-001 AM7)CompletedNCT00464334Phase 1Results posted
- High-Dose PEG-Intron Pharmacokinetic Study in Patients With Melanoma (Study P04831 AM2)CompletedNCT00457418Phase 1Results posted
- Comparison of Sugammadex (Org 25969) With Neostigmine as Reversal Agents for Rocuronium or Vecuronium at Reappearance of T2 (P05960)CompletedNCT00451217Phase 3Results posted
- MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED)CompletedNCT00449956Phase 3Results posted
- Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)CompletedNCT00449930Phase 3Results posted
- Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/ReplacementTerminatedNCT00448864Phase 2Results posted
- RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)CompletedNCT00443846Phase 3Results posted
- MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED)TerminatedNCT00443729Phase 3Results posted
- MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)TerminatedNCT00443703Phase 3Results posted
- Telcagepant (MK-0974) Long-Term Safety Study in Adult Participants With Acute Migraine (MK-0974-012)CompletedNCT00443209Phase 3Results posted
- Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011)CompletedNCT00442936Phase 3Results posted
- Study to Evaluate the Safety and Dose-Range of Navarixin (SCH 527123, MK-7123) in Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (MK-7123-012)TerminatedNCT00441701Phase 2Results posted
- The Effects of PegIntron Plus Rebetol in Subjects With Chronic Hepatitis C Not Responding to Pegasys (Study P03833)TerminatedNCT00441584Phase 3Results posted
- Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED)CompletedNCT00441012Phase 3Results posted
- Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults (V232-059)(COMPLETED)CompletedNCT00440531Phase 3Results posted
- Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060)CompletedNCT00440297Phase 3Results posted
- Safety and Efficacy Study of MK0974 in the Acute Migraine (0974-016)CompletedNCT00432237Phase 3Results posted
- Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)CompletedNCT00432042Phase 3Results posted
- Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by StaphylococciCompletedNCT00428844Phase 2Results posted
- A Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)(0683-066)TerminatedNCT00424775Phase 1Results posted
- Low-dose Temozolomide for 2 Weeks on Brain Tumor Enzyme in Patients With Gliomas (P04602 AM1) (Completed)CompletedNCT00424554Phase 2Results posted
- Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(TERMINATED)TerminatedNCT00423800Phase 3Results posted
- Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523)CompletedNCT00423670Phase 2Results posted
- Clinical Trial of MK0683 in Combination With FDA Approved Cancer Drugs in Patients With Advanced NSCLC (MK0683-058)CompletedNCT00423449Phase 1Results posted
- POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED)CompletedNCT00423267Phase 3Results posted
- Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)TerminatedNCT00423150Phase 2Results posted
- Dose-Finding Pediatric and Adult Trial With Sugammadex (Org 25969, MK-8616, SCH 900616) (19.4.306) (MK-8616-034) (P05961)CompletedNCT00421148Phase 3Results posted
- MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011)CompletedNCT00420420Phase 2Results posted
- A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057)CompletedNCT00414050Phase 3Results posted
- V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)CompletedNCT00411749Phase 2Results posted
- A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)CompletedNCT00411554Phase 3Results posted
- Dyskinesia in Parkinson's Disease (Study P04501)CompletedNCT00406029Phase 2Results posted
- ProQuad® Intramuscular vs SubcutaneousCompletedNCT00402831Phase 3Results posted
- A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)CompletedNCT00399802Phase 2Results posted
- Initial Combination With Pioglitazone Study (0431-064)CompletedNCT00397631Phase 3Results posted
- Sitagliptin Added-on to Insulin Study (0431-051)CompletedNCT00395343Phase 3Results posted
- Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295)CompletedNCT00394914Phase 2Results posted
- Re³ (Re-Cube: Retain Remicade® Response)(Study P04249AM3)TerminatedNCT00394589Phase 3Results posted
- Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED)CompletedNCT00393523Phase 3Results posted
- The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)CompletedNCT00392171Phase 2Results posted
- Exercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036)TerminatedNCT00387036Phase 2Results posted
- Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED)TerminatedNCT00384293Phase 3Results posted
- Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)CompletedNCT00380367Phase 3Results posted
- Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED)CompletedNCT00378599Phase 3Results posted
- V501 Efficacy Study in Women Aged 18 to 26 (V501-027)CompletedNCT00378560Phase 2Results posted
- A Study of Oral Suberoylanilide Hydroxamic Acid (Vorinostat) in Patients With Solid Tumors (0683-048)CompletedNCT00373490Phase 1Results posted
- MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)CompletedNCT00372060Phase 3Results posted
- PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (P04498/MK-4031-278)CompletedNCT00371761Phase 3Results posted
- A Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA (0518-021 EXT)CompletedNCT00369941Phase 3Results posted
- Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422)CompletedNCT00367237Phase 3Results posted
- Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)CompletedNCT00365716Phase 2Results posted
- Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females (V501-005)CompletedNCT00365378Phase 2Results posted
- Developing World Study for RotaTeq™ (V260-015)(COMPLETED)CompletedNCT00362648Phase 3Results posted
- Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563)TerminatedNCT00358670Phase 3Results posted
- Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)CompletedNCT00350779Phase 3Results posted
- Investigation of V520 in a HIV Vaccine Dose Refinement Study (V520-027)(TERMINATED)TerminatedNCT00350623Phase 2Results posted
- Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)(0869-130)(COMPLETED)CompletedNCT00337727Phase 3Results posted
- Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes MellitusCompletedNCT00337610Phase 3Results posted
- Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)CompletedNCT00337428Phase 3Results posted
- Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)CompletedNCT00326183Phase 4Results posted
- Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)CompletedNCT00325130Phase 3Results posted
- A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)CompletedNCT00322231Phase 3Results posted
- Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018)CompletedNCT00314951Phase 3Results posted
- Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)CompletedNCT00312858Phase 4Results posted
- Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)CompletedNCT00305604Phase 3Results posted
- V710 First-In-Man (FIM) Study (V710-001)CompletedNCT00303069Phase 1Results posted
- Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548)CompletedNCT00302081Phase 3Results posted
- Use of Sugammadex at the End of Case in Routine Anesthesia (MK-8616-023)CompletedNCT00298831Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2)CompletedNCT00293267Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019)CompletedNCT00293254Phase 3Results posted
- Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068)CompletedNCT00289913Phase 4Results posted
- Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)CompletedNCT00289900Phase 3Results posted
- MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)CompletedNCT00289848Phase 3Results posted
- Safety and Efficacy of MK0736 & MK0916 in Patients With Hypertension (High Blood Pressure)(0736-003)(COMPLETED)CompletedNCT00274716Phase 2Results posted
- Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED)TerminatedNCT00266812Phase 2Results posted
- The Efficacy and Safety of Pegylated Liposomal Doxorubicin Compared With Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer (P04445/MK-2746-071)CompletedNCT00266799Phase 3Results posted
- Extended Treatment With PEG-Intron® and Rebetol® in Patients With Genotype 1 Chronic Hepatitis C and Slow Virologic Response (Study P03685)CompletedNCT00265395Phase 3Results posted
- V260 Study: Concomitant Use of V260 and INFANRIX™ Hexa in Healthy Infants (V260-010)CompletedNCT00258154Phase 3Results posted
- Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)TerminatedNCT00255034Phase 4Results posted
- Peg-Intron and Rebetol Therapy in Treatment of Naive Hepatitis C Patients: A Comparison of Race and Genotype on Treatment Outcome (Study P04212)TerminatedNCT00255008Phase 4Results posted
- Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)CompletedNCT00254982Phase 3Results posted
- The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED)CompletedNCT00251641Phase 3Results posted
- A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025)TerminatedNCT00251589Phase 1/2Results posted
- A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)CompletedNCT00250432Phase 3Results posted
- A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004)CompletedNCT00246337Phase 2Results posted
- Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Participants (VICTOR-E1) (MK-7690-020/P03672)CompletedNCT00243230Phase 2Results posted
- A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)CompletedNCT00231816Phase 3Results posted
- A Study to Examine the Safety and Tolerability of MK0517 for the Prevention of Post-Operative Nausea and Vomiting (0517-015)CompletedNCT00231777Phase 3Results posted
- Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144)(COMPLETED)CompletedNCT00202839Phase 4Results posted
- V260 Registration Study (V260-013)(COMPLETED)CompletedNCT00166517Phase 3Results posted